CAMP FY 2021 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$296M-4.1% YoY

Gross Profit

$122M41.2% margin

Operating Income

-$15M-5.2% margin

Net Income

-$31M-10.5% margin

EPS (Diluted)

$-0.88

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$18M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$402M

Total Liabilities

$322M

Stockholders' Equity

$80M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$296M	$309M	-4.1%
Gross Profit	$122M	$122M	-0.4%
Operating Income	-$15M	-$4M	-295.8%
Net Income	-$31M	-$21M	-47.2%